Chinese biotech leaders share strategies for advanced therapy development

download Download the report

Download your free report: Combatting Clinical Trial Complexity to Realize Advanced Therapy Potential

Clinical trials for advanced therapies, such as cell and gene therapies and mRNA, are proving increasingly complex for biotech firms, particularly within China. Leaders in the Chinese biotech industry reveal the key factors for success, and share insights on:

  • Identifying the right CRO: Deciding factors in the selection process
  • Successfully handling logistical challenges of mRNA clinical trials
  • How AI and automation is transforming clinical trials, but why caution remains
  • Benefits of multi-national clinical trials in reducing regulatory risks

Simply complete the form
to download your free report.

By ticking this box, you agree to receive emails from Citeline, and carefully selected partners
By completing this form you agree Citeline and Novotech Pty Limited may store and process your personal data as well as contact you directly about industry news, products, services and events that may be of interest to you subject to the privacy polices of Citeline and Novotech Pty Limited.
Pharma Ignite Inspire. Connect. Innovate.
Powered by

Copyright ©️ 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company. Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.